Suppr超能文献

豚鼠离体回肠、输精管和右心房中生长抑素受体的特性研究

Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium.

作者信息

Feniuk W, Dimech J, Humphrey P P

机构信息

Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge.

出版信息

Br J Pharmacol. 1993 Nov;110(3):1156-64. doi: 10.1111/j.1476-5381.1993.tb13935.x.

Abstract
  1. Somatostatin14 (SS14) inhibits neurogenically mediated contractile responses in guinea-pig ileum and vas deferens and exerts a direct negative inotropic action in guinea-pig spontaneously beating right atrium. In this study, the receptors mediating these inhibitory effects have been characterized by comparing the potencies of several cyclic somatostatin analogues. 2. In the guinea-pig ileum, SS14, somatostatin28 (SS28), somatostatin25 (SS25) and several smaller cyclic somatostatin analogues including octreotide, angiopeptin and CGP 23996, inhibited neurogenically mediated contractile responses, each being of similar potency. 3. In contrast, in the guinea-pig vas deferens and right atrium, SS28 was about 30 times more potent than SS14. However, although angiopeptin was nearly as potent as SS14 as an agonist in the vas deferens, in guinea-pig atrium angiopeptin had low intrinsic activity and antagonized the negative inotropic action of both SS14 and SS28 (pKB values of 7.4 and 7.2, respectively). CGP 23996 was 2-7 times weaker than SS14 in guinea-pig vas deferens and atria. 4. Phosphoramidon (1 microM) and amastatin (10 microM) did not influence the potency of SS14 or SS28 in either the guinea-pig ileum or right atrium. In the guinea-pig vas deferens, phosphoramidon and amastatin did not affect the potency of SS28, but enhanced the potency of SS14 about 5 fold. Despite the presence of phosphoramidon and amastatin, SS28 was still more potent than SS14 in the vas deferens. 5. The putative somatostatin receptor blocking drug, cyclo(7-aminoheptanoyl Phe-D-Trp-Lys-Thr[Brl]) (CPP; 1 microM), did not antagonize the effects of either SS14 or SS28 in ileum, vas deferens or atrial preparations. 6. Somatostatin14 did not modify the contractile action of carbachol or alpha,beta-methylene ATP in the ileum and vas deferens respectively, suggesting that the site of the inhibitory effects on neurogenically mediated contractile responses in both preparations was pre-junctional. Consistent with this conclusion was the observation that the inhibitory effect of SS14 was markedly and inversely related to the external Ca2+concentration. The inhibitory effect of SS14 in guinea-pig atrium was only partly dependent on the external Ca2+ concentration.7. The somatostatin receptors mediating the inhibitory effect of SS14 in the ileum and vas deferens can be distinguished by the differential relative potencies of SS14 and SS28. In the former, SS14 and SS28 have similar potency whilst in the latter SS28 is much more potent. In this respect, the somatostatin receptor mediating negative inotropy in the guinea-pig right atrium appears similar to that identified in the vas deferens.8. We suggest that the somatostatin receptor mediating inhibition of neurogenic contraction in the ileum is similar to the recently cloned SSTR2 receptor. In contrast, the somatostatin receptor mediating negative inotropy in the atrium and inhibition of neurotransmission in the vas deferens appears similar to the SSTR4 receptor which recognises SS28 with higher affinity than SS14.
摘要
  1. 生长抑素14(SS14)可抑制豚鼠回肠和输精管中神经源性介导的收缩反应,并对豚鼠自发性搏动的右心房产生直接的负性肌力作用。在本研究中,通过比较几种环生长抑素类似物的效价,对介导这些抑制作用的受体进行了表征。2. 在豚鼠回肠中,SS14、生长抑素28(SS28)、生长抑素25(SS25)以及几种较小的环生长抑素类似物,包括奥曲肽、血管活性肠肽和CGP 23996,均能抑制神经源性介导的收缩反应,且效价相似。3. 相比之下,在豚鼠输精管和右心房中,SS28的效价比SS14高约30倍。然而,尽管血管活性肠肽在输精管中作为激动剂的效价与SS14相近,但在豚鼠心房中,血管活性肠肽的内在活性较低,并能拮抗SS14和SS28的负性肌力作用(pKB值分别为7.4和7.2)。在豚鼠输精管和心房中,CGP 23996的效价比SS14弱2 - 7倍。4. 磷酰胺脒(1微摩尔)和氨肽酶抑制剂(10微摩尔)对豚鼠回肠或右心房中SS14或SS28的效价没有影响。在豚鼠输精管中,磷酰胺脒和氨肽酶抑制剂不影响SS28的效价,但使SS14的效价增强了约5倍。尽管存在磷酰胺脒和氨肽酶抑制剂,在输精管中SS28的效价仍高于SS14。5. 假定的生长抑素受体阻断药物环(7 - 氨基庚酰 - 苯丙 - D - 色 - 赖 - 苏[Brl])(CPP;1微摩尔),在回肠、输精管或心房标本中均未拮抗SS14或SS28的作用。6. SS14分别不改变卡巴胆碱或α,β - 亚甲基ATP在回肠和输精管中的收缩作用,这表明在这两种标本中对神经源性介导的收缩反应的抑制位点是突触前的。与该结论一致的是,观察到SS14的抑制作用与细胞外钙离子浓度显著负相关。SS14在豚鼠心房中的抑制作用仅部分依赖于细胞外钙离子浓度。7. 介导SS14在回肠和输精管中抑制作用的生长抑素受体,可通过SS14和SS28不同的相对效价来区分。在前者中,SS14和SS28效价相似,而在后者中SS28效价高得多。在这方面,介导豚鼠右心房负性肌力作用的生长抑素受体似乎与在输精管中鉴定出的受体相似。8. 我们认为,介导回肠中神经源性收缩抑制作用的生长抑素受体与最近克隆的SSTR2受体相似。相比之下,介导心房负性肌力作用和输精管中神经传递抑制作用的生长抑素受体似乎与SSTR4受体相似,该受体对SS28的亲和力高于SS14。

相似文献

引用本文的文献

5
Somatostatin.生长抑素
Cell Mol Neurobiol. 1995 Dec;15(6):597-614. doi: 10.1007/BF02071127.
7
Molecular pharmacology of somatostatin receptors.生长抑素受体的分子药理学
Naunyn Schmiedebergs Arch Pharmacol. 1994 Nov;350(5):441-53. doi: 10.1007/BF00173012.

本文引用的文献

1
Some quantitative uses of drug antagonists.药物拮抗剂的一些定量应用。
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.
3
Molecular biology of somatostatin receptors.生长抑素受体的分子生物学
Trends Neurosci. 1993 Jan;16(1):34-8. doi: 10.1016/0166-2236(93)90050-v.
5
Somatostatin modulation of peptide-induced acetylcholine release in guinea pig ileum.
Am J Physiol. 1984 May;246(5 Pt 1):G509-14. doi: 10.1152/ajpgi.1984.246.5.G509.
6
Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat.
Peptides. 1982 Sep-Oct;3(5):811-4. doi: 10.1016/0196-9781(82)90020-1.
9
Synthesis and biological actions of prosomatostatin.前生长抑素的合成与生物学作用
Proc Natl Acad Sci U S A. 1980 Oct;77(10):6171-4. doi: 10.1073/pnas.77.10.6171.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验